Ketoconazole in the treatment of dermatomycosis in cats and dogs

Ketoconazole (Nizoral, Janssen Pharmaceutica) a new systemic antimycotic was tested in dermatomycosis in cats and dogs. The daily dose (10 mg/kg body weight) was administered for 10 or 20 days without any other measures being taken. After the 20-day treatments new hair growth was observed in 96.7 per cent of the cats and 89.9 per cent of the dogs. Clinical cure was complete in 96.8 per cent of the cats and 90.5 per cent of the dogs. Particularly the good tolerance in the cat was appreciated. There were practically no side-effects in dogs (except vomiting in two pups) or in cats.     

Ketoconazole in the treatment of dermatomycosis in cats and dogs

Ketoconazole (Nizoral^®, Janssen Pharmaceutica) a new systemic antimycotic was tested in dermatomycosis in cats and dogs. The daily dose (10 mg/kg body weight) was administered for 10 or 20 days without any other measures being taken. After the 20‐day treatments new hair growth was observed in 96.7 per cent of the cats and 89.9 percent of the dogs. Clinical cure was complete in 96.8 per cent of the cats and 90.5 per cent of the dogs.

Particularly the good tolerance in the cat was appreciated. There were practically no side‐effects in dogs (except vomiting in two pups) or in cats.     

Resolution of generalized dermatophytosis without treatment in dogs.

Natural resolution of generalized dermatophytosis reportedly is common in large-animal species. In dogs with generalized dermatophytosis, antifungal treatment usually is prescribed, because the prevalence of natural resolution of dermatophytosis in dogs is not known. Five dogs, 6 to 18 months old, were diagnosed as having generalized dermatophytosis. Each dog was treated with an inert substance given orally with food, once daily. Signs of disease resolved in 3 of the dogs after 4 to 8 weeks of treatment with the inert substance. Two dogs did not improve, so treatment with ketoconazole was initiated. Resolution was achieved in these 2 dogs after 6 weeks of treatment with ketoconazole.     

Ketoconazole for successful treatment of cryptococcosis in a cat

Cryptococcosis affecting the skin and a lymph node in a 1 1/2-year-old cat was treated successfully with ketoconazole as the sole therapeutic agent. The cat was lesion-free 1 year after treatment.     

Treatment of dermatophytosis in dogs and cats: review of published studies

The recent literature on the treatment of dermatophytosis in dogs and cats was reviewed. Based upon in vitro studies using isolated infected hairs and controlled or field in vivo studies, the following topical treatments were consistently found to be antifungal (i.e. antidermatophyte): lime sulfur (1:16), 0.2% enilconazole rinses, and a combined 2% miconazole/chlorhexidine shampoo. Animals or hairs were either bathed or rinsed once or twice weekly. Itraconazole, griseofulvin and terbinafine were evaluated in controlled or field studies, most commonly involving cats. Griseofulvin (50 mg kg(-1)) was reported to cure infected animals in 41-70 days. Itraconazole (10 mg kg(-1) once daily or in a combined daily/pulse therapy 10 mg kg(-1) once daily for 28 days and then week on/week off) was reported to cure infected animals in 56-70 days. Low-dose itraconazole (1.5-3.0 mg kg(-1)) in 15-day cycles required 1-3 cycles (15-45 days). Various doses of terbinafine (5-40 mg kg(-1)) were reportedly used to treat dogs or cats. The higher doses of terbinafine (> 20 mg kg(-1)) were required to achieve a mycological cure; the number of treatment days to cure varied from 21 to > 126 days. Lufenuron was reported anecdotally to be an effective cure, however, this was not substantiated in controlled studies. Finally, fungal vaccines were not found to be effective against challenge exposure, however, there is evidence that they may be useful in treatment protocols.     

盐酸特比萘芬对犬猫皮肤真菌病的疗效观察

笔者2001年7月至2002年1月对盐酸特比萘芬溶液及片剂(癣净溶液、抗癣特片)进行了临床验证,观察其对犬、猫皮肤真菌病的疗效,同时与克霉唑溶液进行平行比较,报告如下。     

Isolation of dermatophytes from dogs and cats with suspected dermatophytosis in Western Turkey

The aim of this study was to determine the species of dermatophytes isolated from dogs and cats and their prevalence in the two big provinces of Western Turkey. A total of 362 animals (198 dogs and 164 cats) with skin lesions (alopecia and desquamation) were examined from March 2006 to February 2008. Of the 362 samples examined, 52 (14.4%) were positive for fungal elements by direct microscopic examination, and 70 (19.3%) were culture positive for dermatophytes. The isolation rates of dermatophyte species from dogs and cats were 18.7% and 20.1%, respectively. Microsporum canis (57.1%) was the most common species isolated from dogs and cats. The prevalence of Trichophyton mentagrophytes was five-fold greater in dogs than in cats (odds ratio=5.226; CI=1.152-23.696). No association was detected between prevalence of infection and provinces, and also sex of dogs and cats. The only risk factor found to be significantly associated with infection was age. Dogs and cats younger than one year of age showed a statistically significant higher prevalence of dermatophytes than other age groups (P<0.05). The isolation rate of dermatophytes was relatively high in the spring and winter for dogs, and in the spring, summer and autumn for cats. However, the association of season and prevalence was found not to be significant.     

Succimer for treatment of lead toxicosis in two cats.

Two cats from a single household were examined because of neurologic abnormalities suggestive of central vestibular disease. The owner had been renovating her 150-year-old house for the preceding 3 months, and renovations included chipping and sanding of old paint from windowsills and stair railings. Lead toxicosis was diagnosed on the basis of history and concentrations of lead in blood and urine. Both cats were treated with succimer. Treatment was not associated with any adverse effects, and both cats recovered completely. Ingestion of old paint from house renovations is the most common source of lead exposure in cats. Owners of cats with gastrointestinal tract or neurologic abnormalities should be questioned specifically about house renovations.     

Immunoprophylaxis of bovine dermatophytosis.

The literature on immunoprophylaxis as control method for ringworm in cattle is reviewed. Scientific papers on immune response to dermatophyte antigens and vaccination against ringworm were obtained from personal files and computerized search in 4 relevant databases. Vaccines with antigens of Trichophyton verrucosum stimulate a humoral and cellular immune response. In animals vaccinated with inactivated vaccines, some protection is observed after challenge. However, the protective immunity is inadequate in most cases. Vaccination with live vaccines elicits an immune response that prevents the development of clinical disease. The protective immunity is based mainly on the cellular branch of the immune system. The efficacy and safety of live dermatophyte vaccines have been demonstrated in both challenge experiments and field trials from different countries. Effective control of ringworm in cattle has been achieved in regions implementing systematic vaccination.     

Use of ketoconazole in treatment of dermatophytosis in a dog

Ketoconazole, an antifungal imidazole derivative, was used successfully to treat Tricophyton mentagrophytes infection in a dog. The drug was administered orally (11 mg/kg of body weight, q 24 h) and continued for 90 days. Though ketoconazole is not licensed currently for veterinary purposes, it has been used successfully to treat dermatophyte infections as well as intermediate and deep fungal diseases in both dogs and cats. In this case, ketoconazole was found to be nontoxic and less expensive than griseofulvin in the treatment of dermatophytosis.     

Safety and immunologic effects after inoculation of inactivated and combined live-inactivated dermatophytosis vaccines in cats

OBJECTIVE: To determine antidermatophyte immunologic effects of an experimental combined live-inactivated dermatophytosis vaccine (CLIDV) and a commercial inactivated dermatophytosis vaccine (IDV) in cats and to evaluate adverse effects associated with administration of these vaccines. ANIMALS: 20 healthy juvenile domestic shorthair cats. PROCEDURE: Cats were injected with 2 doses of CLIDV at the standard dosage or 1 dose of CLIDV at 10 times the standard dosage; IDV was administered at the manufacturer-recommended dosage. Cats were observed for illness and reactions at inoculation sites. Periodically, samples were obtained for fungal culture, lymphocyte blastogenesis test (LBT) as an indicator of cell-mediated immunity against dermatophyte antigens, and antidermatophyte IgG titers. Following vaccination, cats were challenge-exposed by topical application of Microsporum canis macroconidia and examined weekly for clinical signs of dermatophytosis. RESULTS: of 10 cats given CLIDV developed focal crusts at the injection site that resolved without treatment; these were areas of dermatophyte infection with the vaccine strain. Antidermatophyte IgG titers increased significantly with all vaccination protocols. Cellular immunity against M canis increased slightly and variably during the vaccination period and did not differ significantly between vaccinated and control cats. All cats developed dermatophyte infection after challenge exposure. Vaccination with CLIDV or IDV was associated with slightly reduced severity of initial infection. CONCLUSIONS AND CLINICAL RELEVANCE: Noculation with IDV or CLIDV did not provide prophylactic immunity against topical challenge exposure with M canis. Inoculation with either vaccine did not provide a more rapid cure of an established infection.     

Miconazole/chlorhexidine shampoo as an adjunct to systemic therapy in controlling dermatophytosis in cats

A 2 per cent miconazole/2 per cent chlorhexidine shampoo was used in two groups of Persian cats infected with Microsporum canis. In the first group, the cats were treated with griseofulvin alone while, in the second, griseofulvin was used with the shampoo. The clinical signs of the cats were scored on a scale of 1 to 4 for seborrhoea, ease of epilation of hair and the extent of primary lesions, to try to give an overall impression of hair coat condition. The speed of resolution of the infection was assessed in terms of time to mycological cure. Samples were taken from the environment of both groups to assess the degree of environmental contamination at the end of treatment. No statistically significant difference was found between the two groups for time to mycological cure, although the lesion scores in the second group decreased significantly more quickly than those of the first group. Additionally, no dermatophytes were cultured from the environment in the second group at the end of the study.     

Diagnostic techniques for dermatophytosis

This article reviews the use of common diagnostic tools for the identification and isolation of dermatophyte infections in small animals. The use of the Wood's lamp as a screening tool is discussed, along with its usefulness as an aid in the microscopic examination of hairs for fungal elements. Tests for the definitive diagnosis of dermatophytosis are highlighted and include: direct examination of hair for ectothrix spores, fungal cultures, and skin biopsy. Sampling techniques, procedures, and interpretation of test results are also detailed.     

Renal transplantation for treatment of end-stage renal failure in cats.

Renal transplantation was performed as treatment of end-stage renal failure in 23 cats. Twenty-two cats had chronic renal disease and 1 cat had acute renal disease associated with ethylene glycol-induced toxicosis. Sixteen cats were discharged from the hospital. Nine survived a mean of 8.4 +/- 6.5 months, and 7 cats continue to survive at the time of this report (mean 12.6 months). Seven cats died within 2 weeks of surgery. All renal allografts were obtained from unrelated blood-crossmatch-compatible donors. No deaths were attributable to acute renal allograft rejection, demonstrating the successful maintenance of renal allografts by use of cyclosporine and prednisolone immunosuppression in cats.